Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Impact of a Brexit on Oncology Drug Development and Regulation

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 6 of 6
Introduction
Richard M. Marais
Cancer Research UK Manchester Inst., Manchester, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
John S Haurum
Cambridge, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
Susan M. Galbraith
AstraZeneca, Cambridge, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
Joanne M. Hackett
Genomics England, London, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Wrap-up
C. Simone Fishburn
BioCentury, Inc., Redwood City, CA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Panel Discussion
C. Simone Fishburn
BioCentury, Inc., Redwood City, CA, United States
Richard M. Marais
Cancer Research UK Manchester Inst., Manchester, United Kingdom
John S Haurum
Cambridge, United Kingdom
Susan M. Galbraith
AstraZeneca, Cambridge, United Kingdom
Joanne M. Hackett
Genomics England, London, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 6 of 6